MARKET

CLNN

CLNN

Clene
NASDAQ
4.290
+0.370
+9.44%
After Hours: 4.090 -0.2 -4.66% 17:33 02/06 EST
OPEN
4.030
PREV CLOSE
3.920
HIGH
4.350
LOW
4.010
VOLUME
74.86K
TURNOVER
--
52 WEEK HIGH
13.50
52 WEEK LOW
2.280
MARKET CAP
50.53M
P/E (TTM)
-1.2891
1D
5D
1M
3M
1Y
5Y
1D
Major Clene Insider Quietly Trims Stake in Attention-Grabbing Move
TipRanks · 2d ago
10% Owner Chidozie Ugwumba Reports Sale of Clene Inc. Common Shares
Reuters · 2d ago
Major Clene Stakeholder Quietly Trims Position in Back-to-Back Stock Moves
TipRanks · 5d ago
10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares
Reuters · 5d ago
Weekly Report: what happened at CLNN last week (0126-0130)?
Weekly Report · 6d ago
Major Clene Insider Makes Back-to-Back Moves in the Market
TipRanks · 01/29 02:01
10% Owner Chidozie Ugwumba Reports Disposal of Clene Inc. Common Shares
Reuters · 01/28 22:02
Weekly Report: what happened at CLNN last week (0119-0123)?
Weekly Report · 01/26 09:18
More
About CLNN
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. It specializes in the discovery, development, and commercialization of clean-surfaced nanotechnology (CSN) therapeutics. CNM-Au8, the lead asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. CNM-Au8’s mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for the treatment of infectious diseases and to support wound healing.

Webull offers Clene Inc stock information, including NASDAQ: CLNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLNN stock methods without spending real money on the virtual paper trading platform.